1246 Immune related adverse events to checkpoint inhibitors are associated with altered regulatory T cell phenotypes and resemble CTLA4-deficient patients by Maiarana, James, Elonen, Carissa, Beckermann, Katy, Rathmell, Jeffrey, Johnson, Douglas B, Markle, Janet

Get full text

906 Immunogenomic evaluation of clear cell renal carcinoma uncovers HK3 as a myeloid specific metabolic enzyme by Reinfeld, Bradley, Madden, Matthew, Wolf, Melissa, Cubas, Agi de, Haake, Scott, Hongo, Rachel, Axelrod, Margaret, Bader, Jackie, Obradovic, Aleksandar, Greenwood, Dalton, Ye, Xiang, Balko, Justin, Beckermann, Katy, Vincent, Benjamin, Rini, Brian, Drake, Charles, Rathmell, Jeffrey, Rathmell, W

Request full text

Making National Cancer Institute-Designated Comprehensive Cancer Center Knowledge Accessible to Community Oncologists via an Online Tumor Board: Longitudinal Observational Study by Kalra, Maitri, Henry, Elizabeth, McCann, Kelly, Karuturi, Meghan S, Bustamante Alvarez, Jean G, Parkes, Amanda, Wesolowski, Robert, Wei, Mei, Mougalian, Sarah S, Durm, Gregory, Qin, Angel, Schonewolf, Caitlin, Trivedi, Meghna, Armaghani, Avan J, Wilson, Frederick H, Iams, Wade T, Turk, Anita A, Vikas, Praveen, Cecchini, Michael, Lubner, Sam, Pathak, Priyadarshini, Spencer, Kristen, Koshkin, Vadim S, Labriola, Matthew K, Marshall, Catherine H, Beckermann, Katy E, Sharifi, Marina N, Bejjani, Anthony C, Hotchandani, Varsha, Housri, Samir, Housri, Nadine

Get full text